Evolutionary origins of apoB mRNA editing: Catalysis by a cytidine deaminase that has acquired a novel RNA-binding motif at its active site  by Navaratnam, Naveenan et al.
Cell, Vol. 81, 187-195, April 21, 1995, Copyright © 1995 by Cell Press 
Evolutionary Origins of apoB mRNA Editing: 
Catalysis by a Cytidine Deaminase That Has Acquired 
a Novel RNA-Binding Motif at Its Active Site 
Naveenan Navaratnam,* Shoumo Bhattacharya,* 
Takahiro Fujino, Dipti Patel, Adam L, Jarmuz, 
and James Scott 
Medical Research Council Molecular Medicine Group 
Royal Postgraduate Medical School 
Hammersmith Hospital 
Du Cane Road 
London W12 0NN 
England 
Summary 
The site-specific C to U editing of apolipoprotein B100 
(apoBlO0) mRNA requires a 27 kDa protein (p27) with 
homology to cytidine deaminase. Here, we show that 
p27 is a zinc-containing deaminase, which operates 
catalytically like the E. coil enzyme that acts on mono- 
meric substrate. In contrast with the bacterial enzyme 
that does not bind RNA, p27 interacts with its poly- 
meric apoB m RNA substrate at AU sequences adjacent 
to the editing site. This interaction is necessary for 
editing. RNA binding is mediated through amino acid 
residues involved in zinc coordination, in proton shut- 
tling, and in forming the apa structure that encom- 
passes the active site. However, certain mutations that 
inactivate the enzyme do not affect RNA binding. Thus, 
RNA binding does not require a catalytically active site. 
The acquisition of polymeric substrate binding pro- 
vides a route for the evolution of this editing enzyme 
from one that acts on monomeric substrates. 
Introduction 
C to U (and in some cases U to C) editing is extensively 
documented in the mitochondria nd chloroplasts of vas- 
cular plants (Covello and Gray, 1989; Gualberto et al., 
1989; Hiesel et al., 1994). The conversion of multiple C 
to U residues creates mRNAs that can be translated into 
proteins corresponding to those that are genomically en- 
coded by the mitochondrial genomes of species, in which 
editing does not take place. Apolipoprotein B (apoB) 
mRNA undergoes a much more discrete and specific C 
to U editing in the nucleus of certain mammalian cell types 
to generate a stop translation codon and a truncated form 
of apoB called apoB48 (241 kDa) because it is 48% of 
the size of the largest form of apoB, designated apoB100 
(Chen et al., 1987; Powell et al., 1987). ApoB48 is made 
in the enter0cytes of the small intestine and is required 
for the transport hrough the blood of dietary lipid in triglyc- 
eride-rich lipoproteins called chylomicrons. ApoB100 (512 
kDa) is needed for the transport of hepatically synthesized 
lipids and is the sole protein of plasma low density lipo- 
protein. 
The mechanism of apoB mRNA editing is most plausibly 
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a sequence-specific ytidine deamination (Bostrom et al., 
1990; Hodges et al., 1991). The catalytic subunit of the 
apoB mRNA-editing enzyme is a 27 kDa (p27) member 
of the cytosine nucleoside/nucleotide deaminase family 
of enzymes (Navaratnam et al., 1993a; Teng et al., 1993). 
p27 alone is not competent for apoB mRNA editing, but 
requires other cellular factors for RNA targeting. A candi- 
date involved in RNA targeting is a protein of 60 kDa (p60) 
that can be specifically ultraviolet (UV) cross-linked to a 
sequence downstream of the editing site at C6666 in apoB 
mRNA (Navaratnam et al., 1993b). Yet, other cellular fac- 
tors may also be involved. Editing has been proposed to 
be mediated by a large editosomal (as in spliceosomal) 
complex that assembles on apoB mRNA (Harris et al., 
1993). It is also evident that the other factors required for 
editing are expressed in liver cells that normally lack this 
function, as mixing of extracts from human liver cells with 
p27, transfection of liver cell lines with p27, or transduction 
of rabbit liver with p27 is sufficient o produce site-specific 
editing of apoB mRNA (Teng et al., 1993; Giannoni et al., 
1994; Hughes et al., 1994). 
In considering the origin of apoB-type mRNA editing, it 
is important o understand how a cytidine deaminase that 
acts on monomeric substrates might have evolved to mod- 
ify cytidine specifically in an oligoribonucleotide context. 
A priori, this might have occurred by mutation of a cytidine 
deaminase that acts on mononucleotides/nucleosides so 
that it binds to the RNA, or by the association of such 
a deaminase with an RNA targeting subunit(s), or by a 
combination of both. In the present study, we show that 
the catalytic subunit of the apoB RNA-editing enzyme is 
a zinc-containing cytidine residue deaminase, that it has 
acquired the ability to bind to apoB mRNA through its ac- 
tive site and adjacent residues, and that this RNA binding 
is necessary for apoB mRNA editing. 
Results 
Phylogenetic Relationships of the 27 kDa Catalytic 
Subunit of the mRNA Editing Enzyme 
We have previously demonstrated that the catalytic sub- 
unit (p27) of the apoB mRNA-editing enzyme is related 
to the cytidine deaminase family of proteins (Navaratnam 
et al., 1993a). The crystal structure of the Escherichia coil 
cytidine deaminase has recently been established, and 
structural similarities with p27 have been noted (Betts et 
al., 1994). To help identify the structural motifs in p27 that 
are important for site-specific ytidine deamination in an 
oligoribonucleotide context, we have identified cDNA 
clones for the human enzyme and compared the sequence 
of this with the rat RNA-editing cytidine deaminase and 
with other deaminases at the proposed active site of the 
enzymes (Figure 1A). Analysis of the amino acid sequence 
at the active sites of the deaminases (Figure 1B) indicates 
that the CMP/dCMP deaminases and cytidine/deoxycyti- 
dine deaminases form phylogenetically distinct subgroups 
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Figure 1. Domain Organization and Phylogenetic Analysis of the Ac- 
tive Site Regions of RNA-Editing Deaminases and Cytidine Deami- 
nases 
(A) Domain organization of E. coli cytidine deaminase, alignment of 
the active sites in the cytosine nucleoside/nucleotide deaminases and 
RNA-editing deaminases, and site-directed mutants of the rat RNA- 
editing deaminase. The E. coli cytidine deaminase (Betts et al., 1994) 
has two core domains connected by an extended chain. Core domain 
I contains the active site, zinc-liganding residues (arrows), and the 
Glu-104 residue (asterisk) that has the proton shuttle functions. In the 
dimeric enzyme, core domain II covers the active site cleft of the other 
monomer. The site-directed mutants were designed to minimize the 
disturbance to protein secondary structure. 
(13) Phylogenetic analysis of the active site of cytosine nucleoside/ 
nucleotide deaminases and the RNA-editing deaminases. A distance 
matrix was constructed from the alignment of the active site (residues 
60-115 of rat p27) using the program PRODIST, and the phylogenetic 
tree was generated using the program KITSCH (PHYLIP version 3.5c). 
The tree indicates that the active sites of these three types of deami- 
nases has evolved from a common ancestor to achieve the distinct 
substrate specificities observed. 
cordant with the absence of overlap of substrate specificity 
between these two groups of deaminases that act on 
monomeric substrate (Ipata and Cercignani, 1978; Maley, 
1978; Neuhard, 1978; Rothman et al., 1978; Wentworth 
and Wolfenden, 1978). The RNA-editing cytidine deami- 
nases form a third distinct subgroup. 
The deaminases all contain a conserved triad of histi- 
dine (or rarely cysteine), two paired cysteine residues that 
are proposed to coordinate zinc, and a glutamate residue 
proposed to act in a proton shuttle during deamination 
(Figure 1A). Additional residues conserved between the 
human and rat editing enzymes, but not found in any other 
member of the deaminase family, are four phenylalanines 
that reside in the segment that links the proposed active 
site residues. 
Site-Directed Mutagenesis of p27 Identifies 
the Active Site 
To evaluate the structure and function of the catalytic sub- 
unit of the apoB-editing enzyme (p27), we have expressed 
it as a glutathione S-transferase (GST) fusion protein in 
E. coli (GST-p27), and as an influenza haemagglutinin- 
tagged protein (HA-p27) in Sf9 insect cells. Neither GST- 
p27 nor HA-p27 was alone competent for editing, p27 
was only active in the apoB mRNA editing assay, when 
complemented with partially purified rat intestinal extracts 
that had lost editing activity, presumably through loss of 
intrinsic p27. Surprisingly, we found that HeLa cell nuclear 
extract could also complement p27 (data not shown), even 
though HeLa cells express neither p27 nor apoB. Pre- 
viously, we have shown that p27 expressed in Xenopus 
laevis has cytidine deaminase activity (Navaratnam et al., 
1993a). However, neither the E. coli fusion protein nor the 
baculovirus form has this activity. 
The homology of p27 to other deaminases has indicated 
residues that encompass the presumed active site (Figure 
1A) (Navaratnam et al., 1993a; Bhattacharya et al., 1994). 
The crystal structure of the E. coil cytidine deaminase com- 
plexed to the transitional state analog 5-fluoropyrimidine- 
2-1 riboside indicates that the residues His-102, Cys-129, 
and Cys-132 are zinc-coordinating ligands and form the 
active site, together with the Glu-104, which is involved 
in proton transfer functions (Betts et al., 1994). These resi- 
dues correspond to His-61, Cys-93, Cys-96, and Glu-63 
in rat p27 (Figure 1A) and are conserved in the cytosine 
nucleoside/nucleotide deaminase family. 
To establish whether these conserved amino acid resi- 
dues form the active site of p27, site-directed mutagenesis 
of GST-p27 was performed to introduce "safe" changes 
at these residues (Bordo and Argos, 1991; Figure 1A). 
Replacement of His-61 by Ser (H61S) or Arg (H61R), Cys- 
93 and Cys-96 by Ala (C93A and C96A), and Glu-63 by 
Gin (E63Q) abolished editing activity (Figure 2A). Double 
mutants of Cys-93 and Cys-96 (C93A and C96A combined) 
and deletion of amino acid residues 93-96 also abolished 
editing (data not shown). Mutation of the residue Val-64, 
which is not conserved between deaminases, to Leu 
(V64L) had no effect on editing activity (Figure 2A). 
p27 is a Zinc-Dependent Cytidine 
Residue Deaminase 
To investigate the proposal that p27 is a zinc-dependent 
cytidine residue deaminase, we have used zinc-specific 
chelation and site-directed mutagenesis. In the first in- 
stance, HA-p27 expressed in Sf9 cells was incubated with 
a zinc-specific chelating agent, 1,10-o-phenanthroline. 
This abolished the ability of p27 to confer editing activity 
on partially purified rat intestinal extract that has lost this 
activity (Figure 2B). Control incubations with either 1,7-0- 
phenanthroline (Figure 2B) or with the ethanol vehicle 
(data not shown) used for solubilizing this compound had 
no effect. Removal of 1,10-o-phenanthroline and replace- 
ment of zinc by dialysis fully restored editing activity to HA- 
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Figure 2. Mutational Analysis of the Active Site and RNA-Binding 
Sites of p27 
(A) Effect of catalytic and RNA-binding site mutations on ap B mRNA 
editing. Mutation shown is of the zinc-binding ligands (H61R, H61S, 
C93A, and C96A), the glutamate involved in proton shuttling (E63Q), 
a neutral V64L change, and phenylalanine mutants F66L, F70L, F77L, 
and F87L. GST-p27 (WT) and the mutants (1 p,g) were supplemented 
with Mono Q fraction (0.3 p.g) and assayed for editing activity. 
(B) p27 requires zinc for editing. HA-p27 and Mono Q fractions were 
incubated with 1,10- and 1,7-o-phenanthroline f r 10 min. Aliquots of 
HA-p27 (1 p.g) and Mono Q fractions (0.3 I~g) were removed, and 
editing activity was assayed by supplementing with untreated Mono 
Q (0.3 p.g) and HA-p27 (1 I~g), respectively (none). The remaining 
mixtures were dialyzed overnight, and similar aliquots were removed 
and assayed for editing activity as before (buffer). The remainder of 
the mixtures were dialyzed in the presence of zinc, and the editing 
activity was assayed (zinc). 
(C) Zinc binding by wild-type and mutant p27. GST-p27 (WT) and mu- 
tant (C96A, C93A, C93A and C96A combined [C93,96A], deletion of 
Cys-93 to Cys-96 [AC93-96], E63Q, and H61R) GST fusion proteins 
were cleaved with thrombin, separated by SDS-PAGE, and trans- 
ferred to nitrocellulose membranes. Denatured membrane-bound pro- 
teins were renatured in the presence of ~Zn and autoradiographed. 
Coomassie blue-stained wild-type and mutant GST-p27 are shown. 
p27. 1,10-o-phenanthroline had no effect on the activity of 
the complementing fractions of the editing enzyme, indi- 
cating that zinc was not necessary for activity of the com- 
plementing fraction. 
To evaluate the role of p27 residues His-61, Cys-93, 
and Cys-96 in zinc coordinating, mutants in which these 
residues were altered were studied for their ability to bind 
zinc by probing with 6sZn(ll). Mutations C93A, C96A, C93A 
and C96A combined, and deletion of Cys-93 to Cys-96 
reduced zinc binding to background levels (Figure 2C). 
Wild type and H61R, E63Q (Figure 2C), H61S, and V64L 
(data not shown) mutants each bound zinc. These results 
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Figure 3. RNA Editing Deaminase Binding to apoB mRNA 
(A) p27 UV cross-links to apoB mRNA. GST-p27 (1 p.g) or GST-p27 
(1 p.g) after cleavage with thrombin, or GST alone was UV cross-linked 
to apoB RNA (wild-type A-I in Figure 4A). Cross-linked proteins were 
separated on 12o/0 SDS-polyacrylamide gels and stained with Coo- 
massie blue, and the autoradiograph of the same gel is shown, p27 
did not UV cross-link to actin mRNA (Figure 4B), or to globin mRNA 
or antisense wild-type A-I transcript (data not shown). 
(B) UV cross-linking of wild-type and mutant p27 to apoB mRNA. GST- 
p27 (WT) and mutant (H61R, H61S, E63Q, V64L, C93A, C96A, F66L, 
F70L, F77L, and F78L). GST-p27 was UV cross-linked to ~=P-labeled 
RNA and separated on 10% BDS-polyacrylamide gels. Coomassie- 
stained wild-type and mutant GST-p27 are shown. 
are in accord with the crystal structure of E. coli cytidine 
deaminase and with mutagenesis of the E. coli enzyme 
(Betts et al., 1994; Smith et al., 1994). In the E. coli cytidine 
deaminase, zinc is coordinated by His-102, Cys-129, and 
Cys-132. The E. coli mutants of Cys-129 and Cys-132 no 
longer bind zinc, but mutants of His-102 still show signifi- 
cant zinc binding. Thus, in the E. coli cytidine deaminase 
mutants and p27 mutants that alter the histidine, shown 
in the crystal structure of the E. coli enzyme to be involved 
in zinc coordination, zinc is still bound, presumably by the 
two cysteine ligands, p27 is therefore a zinc-containing 
cytidine deaminase with significant active site similarities 
to the E. coli enzyme. 
p27 Binds apoB mRNA through Residues 
Encompassing the Active Site 
p27 was evaluated for its ability to interact with apoB 
mRNA by UV cross-linking. Specific cross-linking of p27 to 
its RNA substrate (Figures 3A and 3B) was demonstrated. 
p27 did not UV cross-link to actin mRNA (see legend to 
Figure 3A). GST alone (Figure 3A) and the E. coli cytidine 
deaminase (data not shown) do not UV cross-link to apoB 
mRNA. As was previously demonstrated, UV cross-linking 
of active editing extract did not identify p27, probably be- 
cause of low abundance (data not shown; Navaratnam et 
al., 1993b). 
To ascertain the amino acid residues involved in RNA- 
protein interaction, mutants of the active site residues and 
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Figure 4. MappingofRNA-EditingDeaminase-BindingSitesonapoB 
mRNA 
(A) Wild-type and deletion mutants of apoB mRNA. Wild-type (A-I) 
apoB mRNA and deletion (A-C, A-D, A-E, C-E, E-G, E-H, E-I, 
F-I, 5'&F, 3'AF, and G-I) mutants of apoB RNA were prepared as 
32P-labeled substrates by T7 promoter-mediated in vitro transcription 
reactions. C6666 is marked by an asterisk. AU-rich sequences are 
underlined. 
(B) UV cross-linking of GST-p27 to apoB RNA. GST-p27 (1 pg) was 
UV cross-linked to wild-type (WT) and deletion mutant (Figure 4A) 
apoB mRNA. Coomassie blue-stained wild-type GST-p27 are shown. 
of other residues encompassing the active site were stud- 
ied. Certain mutants in the catalytic domain of p27 that 
abolish editing (H61S, H61R, E63Q, and C93A) (Figure 
3B), double-mutant C93A and C96A, and deletion of Cys- 
93 to Cys-96 (data not shown) also did not UV cross-link 
to the RNA substrate. The neutral mutant V64L did not 
affect UV cross-linking. The mutant C96A that abolishes 
editing and zinc binding showed only partially reduced UV 
cross-linking to apoB mRNA (Figure 3B). 
A series of phenylalanine residues are conserved be- 
tween rat and human p27 at positions 66, 70, 76, and 
87. In no other deaminases are these residues conserved 
(Figure 1A). Phe-66 resides in the first active site a helix, 
and Phe-70, Phe-76, and Phe-87 reside in the I~ sheet that 
links the two active site a helices (Figure 1A). Mutation 
of residues Phe-66 (F66L) and Phe-87 (F87L) abolished 
editing, but mutation of Phe-70 (F70L) and Phe-76 (F76L) 
had no effect on editing (Figure 2A). F66L, F70L, F76L, 
and F87L each bound zinc to the same extent as wild type 
(data not shown). 
We considered whether Phe-66 and Phe-87 might be 
involved in RNA binding and for positioning p27 for site- 
directed deamination of a C6666. In a variety of RNA- 
binding proteins in which RNA-protein interaction can be 
demonstrated by UV cross-linking, this occurs through 
free radical-driven covalent linkage to aromatic residues. 
The mutants F66L and F87L that do not edit also did not 
UV cross-link to substrate RNA (Figure 3B). Cytidine de- 
aminase activity against monomeric substrate was not re- 
stored in these mutants (method as in Navaratnam et al., 
1993a; data not shown). Mutants F70L and F76L had no 
effect on either editing or cross-linking. These results indi- 
cate that p27 interacts with apoB mRNA through certain 
active site residues in a highly specific manner. Phe-66 
and Phe-87 are also involved in this interaction, as muta- 
tion of these residues abolished editing and UV cross- 
linking. Therefore, RNA binding by p27 is a prerequisite for 
apoB mRNA editing, but RNA editing and UV cross-linking 
can be separated by mutation, as demonstrated by the 
C96A mutant that fails to edit and bind zinc, but binds 
apoB mRNA. A functional active site is not therefore nec- 
essary for RNA binding. 
Mapping of p27 Binding to apoB RNA 
To define the RNA-binding site of p27, we established a 
series of deletion mutants encompassing the apoB 
mRNA-editing and cross-linking substrate (referred to as 
wild-type A-I, nucleotides 6649-6703) (Figures 4A and 
4B). UV cross-linking to GST-p27 is present in deletions 
containing either the AU-rich hexanucleotide segment 
6656-6661 (B-C), or the AU-rich segment 6678-6683 
(E-F), and is lost in deletions lacking both these segments. 
This maps the binding site of GST-p27 to these two AU- 
rich segments. Experiments with other mutants (A-H, 
A-G, A-F, B-I, C-I, D-I, B-E, and C-F) were also per- 
formed (data not shown). These were shown to cross-link 
to GST-p27, confirming the above mapping data. The AU 
sequences in mutants containing the F segment cross- 
linked better than those containing only the B segment. 
The presence of both AU-rich sequences did not enhance 
UV cross-linking compared with mutants with a single AU- 
rich sequence (compare wild-type A-I with E-I in Figure 
4B). Actin mRNA did not UV cross-link. 
Previously, we and others have shown that nucleotides 
present in B-C can be deleted without abolishing editing 
and that conversion of the segment B to its complement 
and certain point mutations in this region enhance rather 
than reduce editing (Backus and Smith, 1991; Shah et al., 
1991). In contrast, mutations of F to its complement and 
point mutation of this sequence substantially reduce or 
abolish editing. Together, these results suggest that p27 
binding to the region F is important for editing. We there- 
fore generated 5'•F and 3'AF, each of 21 nucleotides, 
by the deletion of three 5' or 3' nucleotides, respectively 
(Figure 4A). The mutant 5'z~F showed weak UV cross- 
linking, whereas 3'AF UV cross-linked to p27 comparably 
to F-I and wild-type A-I, and better than A-C, A-D, A-E, 
E-H, and E-G. These results indicate that the segment 
E-F (nucleotides 6678-6683) contains the critical nucleo- 
tides for p27 binding, but that the AUU sequence in the 
segment I may contribute to UV cross-linking. 
We considered that p27 might preferentially bind AU- 
containing RNA sequences, because of nucleotide con- 
tent rather than sequence. To test this, the effect of compe- 
tition with polyadenylic acid (poly[A]), polycytidylic acid 
(poly[C]), polyguanidylic acid (poly[G]), polyuridylic acid 
(poly[U]), polycytidylic and polyguanidylic acid double- 
stranded homopolymer (poly[C]- [G]), polyadenylic and poly- 
uridylic acid double-stranded homopolymer (poly[A]-[U]), 
polyadenylic-polyuridylic-polyuridylic acid triple-stranded 
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Figure 5. EffectofSyntheticPolyribonucleotidesonp27apoBmRNA 
Editing and Binding 
(A) Effect of synthetic polyribonucleotides on apoB mRNA editing. 
GST-p27 (1 ~g) was supplemented with Mono Q (0.3 p.g) fractions in 
the absence (minus) and presence of indicated polyribonucleotides 
(polyadenylic acid, [A]; polyguanidylic acid, [G]; polycytidylic acid, [C]; 
polyuridylic acid, [U]; polycytidylic and polyguanidylic acid, [C].[G]; 
polyadenylic and polyuridylic acid, [A].[U]; polyadenylic-polyuridylic- 
polyuridylic acid [A].[U].[U]; polyadenylic and cytidylic acid [A,C]; 
polycytidylic and uridylic acid [C,U]; polyguanidylic and uridylic acid 
[G,U]; polyadenylic and guanidylic acid [A,G]; polyadenylic and uridylic 
acid [A,U]; 300-fold excess of [A],[G],[C],[U], 150- and 300-fold excess 
of other polyribonucleotides) and was assayed for editing activity. Edit- 
ing reactions were set up as described. 
(B) Effect of polyribonucleotide AURNA on UV cross-linking. UV cross- 
linking of GST-p27 (1 ~g) to wild-type (w-r) A-I RNA was competed 
with the indicated fold excess of competitor (poly [A,U], yeast total 
RNA, WT A-I) over labeled substrate. 
(C) Effect of deletion mutants on UV cross-linking. UV cross-linking 
of GST-p27 (1 p.g) to WT A-I was competed with the indicated fold 
excess of competitor (A-E, C-E, and E-I) over labeled substrate. 
homopolymer (poly[A] • [U]- [U]), polyadenylic and cytidylic 
acid (poly[A,C]), polycytidylic and uridylic acid (poly[C, U]), 
polyguanidylic and uridylic acid (poly[G,U]), polyadenylic 
and guanidylicacid (poly[A,G]), and polyadenylic and uri- 
dylic acid (poly[A,U]) on editing activity and on UV cross- 
linking was examined (Figure 5). Poly[A,U] RNA com- 
pletely abolished editing in a concentration-dependent 
manner (Figure 5A). Poly(U) competition also reduced lev- 
els of editing. Other polynucleotides had little or no effect. 
p27 showed strong affinity for poly(A,U) RNA in UV cross- 
linking studies (Figure 5B), but little or no affinity for other 
polyribonucleotides (data not shown) or control yeast total 
RNA. Competition for the UV cross-linking of p27 to the 
segment wild-type A-I was also performed with segments 
A-E, C-E, and E-I. A-E and E-I both contain AU-rich 
sequences and were effective competitors, with E-I being 
better than A-E. C-E did not compete. We suggest that 
p27 has affinity for AU-rich sequences and binds these 
sequences both upstream and downstream of the editing 
site, but that the latter is the necessary binding for editing 
to occur. 
ooo  
Figure 6. Schematic Representation of the Active Site of the RNA- 
Editing Cytidine Deaminase 
The diagram shows zinc coordinated by His-61 (H61), Cys-93 (C93), 
and Cys-96 (C96) and the proton-shuttling lutamate Glu-63 (E63). 
Conserved phenylalanines Phe-66 (F66), Phe-70 (F70), Phe-76 (F76), 
and Phe-87 (F87) are shown in the linking 13 segment between the 
active site ~ helices. RNA binding is mediated by His-61, Glu-63, Phe- 
66, Phe-87, and Cys-93. This diagram is based on a cartoon in Betts 
et al. (1994). 
Discuss ion  
The present study establishes that the catalytic subunit 
of the apoB mRNA-editing enzyme is a member of the 
zinc-containing cytidine deaminase family of enzymes and 
that the tertiary structure of E. coli cytidine deaminase 
active site is conserved in the editing enzymes (Betts et 
al., 1994). In distinction from the E. coli enzyme, the editing 
enzymes form a phylogenetically separate subgroup of 
enzymes that have evolved the capacity to deaminate cyti- 
dine in an oligonucleotide context through binding apoB 
mRNA by residues used for zinc binding, proton shuttling, 
and forming the ~13a structure that encompasses the ac- 
tive residues of the enzyme (Figures 1 and 6). 
We and others have previously shown that the editing 
activity of rat intestinal extracts is dependent on zinc (Na- 
varatnam et al., 1993a; Barnes and Smith, 1994). In the 
present study, we have shown that chelation with 1,10-o- 
phenanthroline specifically inhibits the activity of ex- 
pressed p27. Replacement of zinc by dialysis reactivates 
the enzyme, demonstrating that the activity of expressed 
p27 requires zinc. The partially purified p27 complement- 
ing activity needed for editing from rat small intestine or 
heterologous complementing activity from HeLa cell splic- 
ing extracts is not inhibited by 1,10-o-phenanthroline and 
is therefore not zinc dependent. Thus, the zinc-dependent 
component of the editing activity is the p27 catalytic sub- 
unit of the apoB mRNA-editing complex. 
Zinc is required for the activity of related deaminases, 
such as bacteriophage T4 dCMP deaminase and adeno- 
sine deaminase, and is present at the active site of E. 
coil cytidine deaminase (Wilson et al., 1991 ; Moore et al., 
1993; Betts et al., 1994). The recently determined crystal 
structure of E. coli cytidine deaminase indicates that the 
active site of this enzyme is formed by an ~ motif (Fig- 
ures 1 and 6), which contains the three zinc-coordinating 
residues His-102, Cys-129, and Cys-132 and the proton- 
shuttling residue Glu-104. The C4 of cytidine undergoes 
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a nucleophilic attack by the zinc-bound hydroxide. The 
Glu-104 residue has three roles: activation of the zinc- 
bound water, protonation of the N3 on cytidine, and shut- 
tling of the proton from the zinc-bound hydroxide to the 
leaving ammonia. This results in the conversion of cytidine 
to uracil with the production of ammonia. The above resi- 
dues are conserved in other cytosine nucleosidelnucleo- 
tide deaminases, and in p27, in which presumably they 
also form the active site. 
We introduced "safe" mutations at the potential zinc- 
binding amino acids in p27 (H61R, H61S, C93A, and 
C96A) by site-directed mutagenesis (Figures 1 and 6). The 
mutations were based on the preferred amino acid substi- 
tution matrix and are least likely to disturb protein second- 
ary structure (Bordo and Argos, 1991). We also mutated 
the Glu-63 residue to Gin (E63Q), which would be ex- 
pected to block the formation of the first tetrahedral inter- 
mediate and other essential catalytic functions of this resi- 
due (Figures 1 and 5). These mutations abolished editing 
activity totally. Wild type and H61R, H61S, and E63Q mu- 
tants retained some ability to bind zinc, whereas none of 
the mutants C93A, C96A, C93A and C96A combined, and 
deletion of Cys-93 to Cys-96 bound zinc. This is consistent 
with mutations of comparable residues of the E. coli cyti- 
dine deaminase in which C129A and C132A failed to bind 
zinc but H102Q and H102N continued to bind zinc (Smith 
et al., 1994), presumably through the paired cysteine at 
the active site. These results indicate that the zinc-binding 
and catalytic mechanism of p27 is similar to that of the 
E. coli cytidine deaminase, p27 is therefore stablished as 
a member of the family of enzymes that act on monomeric 
nucleotide and nucleoside substrates. 
p27, along with other factors, has acquired the ability 
to deaminate apoB mRNA in a site-specific manner, but 
p27 no longer has cytidine deaminase activity against 
monomeric substrate except when expressed in Xenopus 
laevis oocytes (unpublished data; Navaratnam et al., 
1993a). We show here that p27 binds RNA, whereas the E. 
coli enzyme does not. p27 needs the zinc-binding residues 
His-61 and Cys-93 and the proton-shuttling residue Glu-63 
(Figures 1 and 6) to bind apoB mRNA, but does not require 
Cys-96. In contrast, Cys-96 is required for zinc coordina- 
tion and for RNA editing, demonstrating dissociation of 
the catalytic and RNA-binding function of the active site 
residues of p27. RNA binding by p27 does not require a 
functional active site. RNA editing, however, requires a 
functional active site that binds both zinc and apoB mRNA. 
Phe-66 and Phe-87 are important for RNA cross-linking 
to p27 and for RNA editing. These residues reside in the 
a~a segment hat encompasses the active site of the en- 
zyme and are conserved between the rat and human cata- 
lytic subunits, and in no other deaminases. The phenylala- 
nines at positions 70 and 77 in the rat and human enzymes 
do not appear to be involved in RNA-p27 interaction. In the 
recently reported sequence of the rabbit editing enzyme, 
Phe-66 and Phe-87 are conserved, but Phe-70 and Phe-77 
are not (¥amanaka et al., 1994). Thus, p27 binds apoB 
mRNA through residues both in and around its active site, 
and RNA binding by p27 is a prerequisite for editing. 
Although the structure of p27 is unlike that of other RNA- 
binding proteins (Burd and Dreyfuss, 1994), aromatic resi- 
dues have been implicated in the UV cross-linking of RNPs 
(RRMs) to the small nuclear RNAs involved in splicing and 
other RNA-processing events. Histidine has been similarly 
(though less frequently) implicated. These aromatic groups 
probably stack with the nucleotide bases of the RNA. Pro- 
teins such as TFIIIA that use zinc to stabilize protein struc- 
ture, rather than in catalysis, bind RNA through zinc fin- 
gers. However, it seems unlikely that zinc per se is 
involved in apoB mRNA binding, since both C93A and 
C96A fail to bind zinc, but C93A abolishes UV cross-linking 
while C96A does not. Also, H61S abolishes UV cross- 
linking, but not zinc binding. The importance of the proton- 
shuttling residue Glu-63 in RNA binding is unexpected, 
since RNA is highly negatively charged. It is possible that 
Glu-63 is located in proximity to other residues that it helps 
to position for RNA binding, by association with phosphate 
oxygens from the substrate RNA, and that the negative 
charge of this residue is neutralized. On the other hand, 
Glu-63 could bind directly to the bases in the RNA, as has 
recently been shown for MyoD binding to target DNA, in 
which Glu-118 makes a water and hydrogen bond-medi- 
ated contact to the base residues (Ma et al., 1994). Other 
parts of p27 may also be involved in RNA binding. Deletion 
of 14 amino acids from the amino terminus and 5 amino 
acids from the carboxyl terminus abolish RNA editing and 
UV cross-linking (unpublished ata), suggesting that these 
regions may also contribute to the interaction of p27 with 
the RNA. 
A number of enzymes interact with RNA. These include 
the iron regulatory protein/aconitase, thymidylate syn- 
thase, dihydrofolate reductase, catalase, glyceraldehyde- 
3-phosphate dehydrogenase, glutamate dehydrogenase, 
and lactate dehydrogenase (Hentze, 1994). Although the 
amino acids that are directly involved in RNA binding are 
not known for any of these enzymes, Hentze (1994) identi- 
fied a striking common denominator in that their catalytic 
reactions involve mono- or dinucleotides as substrates or 
cofactors, or that their structure contains occult nucleo- 
tide-binding sites such as are found in aconitase and cata- 
lase. A feature of the first three of these enzymes is that 
nucleotides compete for RNA binding, suggesting that the 
nucleotide-binding sites and RNA-binding sites may over- 
lap. It has been suggested that enzymatic domains that 
interact with nucleotides could have evolved into binding 
surfaces for polyribonucleotides. Indeed, RNA-binding do- 
mains with homology to (di)nucleotide-binding sites do not 
appear necessarily to still bind the dinucleotide itself as 
with aconitase and catalase. This is probably also the case 
with p27. The E. coli p27 fusion protein and baculovirus- 
expressed form no longer have cytidine deaminase activ- 
ity. Also, cytidine and its analogs do not affect RNA editing 
(unpublished data; Driscoll et al., 1989; Greeve et al., 
1991). Thus, as Hentze has suggested, the relationship 
between (di)nucleotide binding and RNA binding provides 
an evolutionary pathway for the development of RNA bind- 
ing from a more simple monomeric or dimeric nucleotide 
binding function. It appears that this editing enzyme has 
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evolved because of mutations that have facilitated binding 
to RNA and that active site residues involved in cytidine 
nucleoside/nucleotide binding and deamination are also 
involved in RNA binding and deamination. However, a 
functional active site is not required for RNA-protein inter- 
action. Additional aromatic residues are needed for RNA- 
protein interaction and editing, but mutation of the phenyl- 
analine residues involved in RNA binding is not sufficient 
to restore cytidine deaminase activity against monomeric 
substrates. 
Previously, we have studied the nucleotides necessary 
for the editing of apoB m RNA at C6666 in vitro. A sequence 
of 26 nucleotides that is highly conserved between species 
is required for editing (positions 6662-6687) (Davies et 
al., 1989). This sequence contains a core element of 11 
nucleotides (positions 6671-6681), placed 5-15 nt down- 
stream of the edited C6666, which if mutated abolishes 
editing (Backus and Smith, 1991; Shah et al., 1991). Up- 
stream and downstream of this core element, mutation of 
the adjacent hexanucleotide segments substantially re- 
duces editing. We now show that p27 associates with an 
AU-rich sequence (positions 6678-6683) overlapping with 
and downstream of this core sequence and less strongly 
with an AU-rich sequence upstream (positions 6656- 
6661) of the editing site. The presence of the upstream 
AU sequence is not needed for editing, whereas the down- 
stream sequence is needed for editing (Davies et al., 1989; 
Backus and Smith, 1991; Shah et al., 1991). p27 binding 
to the downstream AU-rich sequence appears to be of 
relatively low specificity, as mutagenesis to its comple- 
ment reduces but does not abolish editing (Shah et al., 
1991). This view is supported by the competition studies 
with poly(A,U) and poly(U) RNA reported here. The high 
AU content of the overall sequence surrounding the editing 
site may serve to guide p27 to this region of the RNA 
(Davies et al., 1989), but the upstream AU sequence may 
also compete with the downstream sequence as mutagen- 
esis of the upstream sequence to reduce its AU content 
enhances editing in vitro (Backus and Smith, 1991; Shah 
et al., 1991). 
The findings that p27 binds through its active site to an 
AU sequence downstream of the edited C suggests that 
this sequence and the edited C must be brought into close 
proximation in the substrate RNA. A role for the active site 
in AU-rich sequence binding might prevent this region of 
the substrate from interfering with the primary RNA- 
binding site at C6666. p27 may dimerize or multimerize 
with itself, as does the E. coli enzyme, and different mole- 
cules of p27 interact with the AU sequence and edited C 
(Maley et al., 1990; Lau et al., 1994). 
p27 alone is not competent for editing. It requires other 
factors that can be derived both from tissues that express 
apoB mRNA and also from HeLa cells and mammalian 
liver cells that do not (Teng et al., 1993; Giannoni et al., 
1994; Hughes et al., 1994; this study). This might imply 
that the complementing factors necessary for apoB mRNA 
editing are widely expressed because of the editing of 
other mRNAs, or that other nonspecific cellular compo- 
nents complete this activity. In either case, it is likely that 
recognition of the apoB mRNA-editing site is highly spe- 
cific; otherwise, this activity would be deleterious for the 
genome. We have previously identified a 60 kDa protein 
that binds specifically to the apoB mRNA substrate at nu- 
cleotides 6671-6674 (UGAU) that are required for editing 
(Navaratnam et al., 1993b). Mutation of these nucleotides 
completely abolishes the binding of p60. We have specu- 
lated that p60 might be part of the RNA targeting mecha- 
nism of the editing enzyme, but in the absence of purified 
or expressed p60 we are not able to confirm this. It is 
possible that p60, in association with other proteins with 
chaperone or matchmaker functions, might bring the ed- 
ited cytidine and the binding site of p27 into close proxi- 
mation (Burd and Dreyfuss, 1994). 
In conclusion, in this study, we have shown that the 
catalytic subunit of the apoB mRNA-editing enzyme is a 
zinc-containing cytidine residue deaminase operating by 
the same mechanism as the E. coli enzyme that acts on 
mononucleotides/nucleosides. The editing enzyme has 
evolved away from the enzymes that act on monomeric 
substrates by binding to the edited nucleotide in an oligori- 
bonucleotide context hrough its active site and other resi- 
dues. For editing to take place, the 27 kDa catalytic subunit 
of the apoB mRNA-editing enzyme also needs comple- 
menting nuclear factors that are expressed in cells that 
do not normally express or edit apoB mRNA. Together, 
these studies illustrate how structural changes in the fam- 
ily of enzymes acting on cytidine nucleosides/nucleotides 
have contributed to the origins of this type of editing 
through the adaptation of enzymatic function. We specu- 




All reagents were from Sigma unless otherwise stated. 
Oligonucleotides 
The following oligonucleotides were used in this study and are shown 
5' to 3', with restriction sites or mutated codons in bold. P275Bam, 
GAATTCGGATCCTCCGAGACAGGCCCTGTAG; P273Bam, 
GGCCAGGATCCTCATI-ICAACCCTGTGGC; P273Sal, GGCCAGT- 
CGACTCATTTCAACCCTGTGGC; 5END, ACACAGATCTCAAGAT- 
GAGTTCCGAGACAG; 3TAG, CATAGGATCCTCATTAAGCATAA- 
TCTGGAACATCATATGGATATTTCAACCCTG TGGCCCACAG; 
SallToggle, GGTTTCTTAGTCGACAGGTGGCAC; GST1, GCATGG- 
CCTTTGCAGGGCTG; H61S, AACACCAACAAATCCGTTGAAGT- 
CAA; H61 R, ACCAACAAACGCGTTGAAGTC; H61R(R), GACTT- 
CAACGCGTTTGTTGGT; E63Q, CAAACACGTTCAAGTCAATTTC; 
V64L, CACGTTGAACTCAATTTCATA; V64L(R), TATGAAATFGAGT- 
TCAACGTG; C93A, CTGTCCTGGAGTCCCGCTGGGGAGTGCTC- 
CAG; C93A(R), CTGGAGCACTCCCCAGCGGGACTCCAGGACAG; 
C96A, AGTCCCTGTGGGGAGGCCTCCAGGGCCATTACAG; 
C96A(R), CTGTAATGGCCCTGG AGGCCTCCCCACAGGGACT; 
A9396, TTGTTCCTGTCCTGGAGTCCCTCCAG GGCCATTACA- 
GAATTTTTG; A9396(R), CCTGGAGGGACTCCAGGACAGGAAC- 
CAG; C9396A, CTGTCCTGGAGTCCCGCTGGGGAGGCC; 
C9396A(R), TGTAATGGCCCTGGAGGCCTCCCCAGCGGGACT; 
F66L, GAAGTCAATTTGATAGAAAAAI-ICC; F66L(R), A I t t t t CTAT- 
CAAATTGACI-IC; F70L, TAGAAAAATTGACTACAGAAAG; F70L(R), 
CTTTCTGTAGTCAATTTTTCTA; F76L, GAAAGATACTTGTGTC- 
CAAAC; F76L(R), GTTTGGACACAAGTATCTTTC; F87L, CATTACC- 




Isolation of Human p27 cDNA 
A human small intestinal ibrary (Clontech Lab) was screened with a 
rat cDNA probe, using standard protocols. 
Conversion Assays and Primer Extension Analysis 
Conversion and primer extension assays were performed as described 
previously (Navaratnam et al., 1993a, 1993b), using a 208-base (nu- 
cleotides 6510-6717) rat apoB mRNA substrate and recombinant p27 
(typically 1 p.g) supplemented with 0.3 Lug of complementing Mono Q 
fraction protein. 
Partial Purification of p27 Complementing Activity 
Editing extracts were prepared as previously described from rat intesti- 
nal epithelium (Navaratnam et al., 1993a, 1993b) with the following 
modifications. Active fractions from the heparin-Sepharose were 
pooled and applied to poly(U)-Sepharose preequilibrated in buffer A 
(20 mM HEPES, 1 mM EDTA, 1 mM ~-mercaptoethanol [pH 7.9]). The 
column was washed in buffer A, followed by buffer A with 1 mg/ml 
heparin (Sigma), followed by three column volumes of buffer A. The 
column was eluted by a 0.2 to 0.6 M linear NaCI gradient in buffer A. 
Fractions containing p27 complementing activity were pooled, dia- 
lyzed against buffer A, and applied to Mono Q Sepharose (Pharmacia) 
preequilibrated in buffer A. This was eluted with 0 to 0.6 M linear NaCI 
gradient. The fractions eluted from the Mono Q lack intrinsic editing 
activity, but can complement he p27 catalytic subunit. 
HeLa Cell Nuclear Extract 
HeLa cell nuclear extract was purchased from Promega and was dia- 
lyzed against 20 mM HEPES buffer (pH 7.9) containing 1 mM EDTA, 
10% glycerol and was used directly in the experiments. 
Expression of p27 in E. coil 
p27 was expressed in E. coil as a GST fusion protein. The p27 insert 
was produced by polymerase chain reaction (PCR) from the cDNA 
sequence as described (Teng et al., 1993), using oligonucleotides 
P275Bam and P273Bam using Pfu polymerase (Stratagene). The PCR 
product was digested with BamHI, ligated into pGEX2T/BamHI (Phar- 
macia), and transformed into E. coil DH5,xF' cells, and the DNA se- 
quence of the insert was verified. Cells were grown to an OD of 0.7 
and induced with 0.05 mM IPTG for 30 min at 28°C. GST-p27 was 
affinity purified using glutathione-Sepharose (Pharmacia) following 
the instructions of the manufacturer. Protein content was assayed 
using the Bradford reagent (Bio-Rad). 
Expression of p27 in Sf9 cells 
A p27 insert with a 3' HA tag was produced by PCR as above, using 
oligonucleotides 5END and 3TAG, and cloned into pVL1393/BamHI 
that was cotransfected into Sf9 cells using the Baculogold kit (Phar- 
mingen). Recombinant virus was transfected as recommended by the 
manufacturer, cells were harvested after 3 days, lysed in buffer A with 
Triton 0.1%, and centrifuged, and the supernatant collected. 
Site-Directed Mutagenesis 
Mutants H61S and E63Q were made in GST-p27 using the unique 
site elimination technique (Deng and Nickloff, 1992) with the oligonu- 
cleotides (H61S and H61R) and the Sail-Toggle, which converts a 
unique Aatll site in the pGEX2T/p27 construct o Sail. The other mu- 
tants were made by PCR using the splicing by overlap extension tech- 
nique. Complementing mutagenic oligonucleotides (e.g. V64L and 
V641(R)) were used to generate two overlapping PCR products, using 
the upstream primer GST1 and the downstream primer p273Sall. The 
overlapping products were isolated by agarose gel electrophoresis 
and spliced in a further round of PCR. The product was digested with 
BamHI and Sail, and directionally cloned into pGEX4T3/BamHI/SalI. 
The amino acid sequence of the GST-p27 junction is thus identical 
in all constructs. All mutant constructs were sequenced to confirm the 
mutated residue and the absence of adventitious mutations. Fusion 
proteins were expressed as above. 
Chelation and Zinc Binding Studies 
Stock solutions (1 M) of 1,10- and 1,7-o-phenanthroline (Sigma) were 
prepared in 100%o ethanol. To 594 I11 of Mono Q fraction or Sf9 superna- 
tant, 6 pl of 1,10- or 1,7-o-phenanthroline or ethanol was added. The 
mixture was incubated at 30°C for 10 min, and 50 ILl aliquots were 
removed and stored at 4°C. The remainder was dialyzed against buffer 
A containing 10 m M p-mercaptoethanol vernight. Aliquots (50 pl) were 
removed, and dialysis was continued in the same buffer containing 5 
mM zinc sulphate for 6 hr, following which the buffer was changed to 
buffer A and dialysis continued overnight. Aliquots were then assayed 
for editing activity. 
Zinc Binding Studies 
Wild-type and mutant GST fusion proteins were purified using glutathi- 
one-Sepharose. The matrix with bound proteins was washed by rock- 
ing overnight with 100 bed volumes of phosphate-buffered saline at 
4°C. Purified fusion proteins were cleaved with thrombin in the pres- 
ence of 20 p_M heparin overnight at 250C. The supernatant was con- 
centrated on a Centricon C-10 (Armicon), fractionated on a 12% gel 
by SDS-PAGE at 4°C, and blotted onto nitrocellulose membrane in 
CAPS (pH 11), methanol 10% buffer for 75 min. Proteins on the blot 
were denatured overnight in metal binding buffer (Mazen et al., 1988) 
containing 6 M guanidium hydrochloride and 1%0 ~-mercaptoethanol 
at 4°C and renatured in six steps by diluting the guanidium with an 
equal volume of metal binding buffer containing 1% I~-mercapto- 
ethanol, followed by two washes with metal binding buffer containing 
1%0 [3-mercaptoethanol. The denaturation/renaturation step markedly 
improved the zinc binding signal. Following the final step, the blot was 
rinsed twice with metal binding buffer and then incubated with ~ZnCI2 
(Amersham) at 1 p.Ci/ml in metal binding buffer for 30 min at room 
temperature. The blot was washed in eight changes of metal binding 
buffer for 30 min, air dried, and autoradiographed on Kodak X-OMAT 
using a screen at -70°C for 8 hr. 
UV Cross-Linking Studies 
Wild-type (A-I) and deletion (A-C, A-D, A-E, C-E, E-G, E-H, E-I, 
F-I, 5'ADF, 3'ADF, and G-I) RNA transcripts used in the UV cross- 
linking studies were synthesized by T7-directed in vitro transcription 
reactions in the presence of [a-~P]UTP (Amersham). All reagents used 
were obtained from Ambion Biotechnology Limited. Templates for T7 
transcription were generated by PCR (Milligan et al., 1987). Hindlll- 
linearized plasmid pBS 55 (Shah et al., 1991) was used as the template 
in the PCR reactions. 5' oligonucleotides for PCR were generated by 
appending a 23 nt T7 promoter sequence (GGA TCC TAA TAC GAC 
TCA CTA TAG GGA TCC GG) to 5' end (12 nt) of the desired template. 
3' oligonucleotides were complementary to the required 3' end of the 
template. UV cross-linking studies were performed as before (Navarat- 
nam et al., 1993b). GST-p27 wild-type or mutant protein ( -  1 Pg) was 
incubated with ~P-labeled RNA at 30°C for 20 rain and UV cross-linked 
for 10 rain on ice. Cross-linked products were separated on 10% or 
12% SDS-PAGE gels. Gels were stained with Coomassie blue, and 
dried gels were subjected to autoradiography. 
Competition studies were performed as previously described (Shah 
et al., 1991) with polyribonucleic acids. 
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